belladonna

Clinical trial activity

8 trials · 9 clinical orgs · 0 marketing orgs

Earliest trial started Mar 17, 2009 (NCT00863928)

Indications

Mechanism of action

• Unspecified targetOTHER

  Unknown

  Scientific evidence to recommend the use of A. belladonna in its natural form for any condition is insufficient, although some of its components, in particular l-atropine, which was purified from belladonna in the 1830s, have accepted medical uses. Donnatal is a pharmaceutical prescription, approved in the United States by the FDA, that combines natural belladonna alkaloids (atropine and scopolamine) in a specific, fixed ratio with phenobarbital to provide peripheral anticholinergic/antispasmodic action and mild sedation. According to its labeling, it is possibly effective for use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.

• Unspecified targetUnclear

  unclear

  Scientific evidence to recommend the use of A. belladonna in its natural form for any condition is insufficient, although some of its components, in particular l-atropine, which was purified from belladonna in the 1830s, have accepted medical uses. Donnatal is a pharmaceutical prescription, approved in the United States by the FDA, that combines natural belladonna alkaloids (atropine and scopolamine) in a specific, fixed ratio with phenobarbital to provide peripheral anticholinergic/antispasmodic action and mild sedation. According to its labeling, it is possibly effective for use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.